Bridget A Martell
CIK 1629627 · Acting Chief Medical Officer · last filed 2026-06-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
7
Total Filings
20
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALGS | Director | — | $4.25 | — | $0 | 7 | 2026-06-29 |
| DCTH | Director | — | $11.55 | — | $0 | 3 | 2026-05-14 |
| ACHV | Director | — | $6.18 | — | $0 | 5 | 2025-06-10 |
| POINT Biopharma Global Inc. (PNT) Delisted | Director | — | $12.50 | — | $0 | 1 | 2023-06-14 |
| KURA | Acting Chief Medical Officer | — | $9.31 | — | $0 | 1 | 2020-02-12 |
| JUNIPER PHARMACEUTICALS INC (JNP) Delisted | Chief Medical Officer | 15,500 | — | — | $0 | 2 | 2017-03-07 |
| JUNIPER PHARMACEUTICALS INC (CBRX) Delisted | Chief Medical Officer | — | — | — | $0 | 1 | 2015-01-09 |
Recent Filings · Page 2 of 2
20 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-14 | POINT Biopharma Global Inc. (PNT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | ACHV | Grant (A) | — | $0 | EDGAR |
| 2022-06-27 | ALGS | Grant (A) | — | $0 | EDGAR |
| 2022-06-01 | ACHV | Grant (A) | — | $0 | EDGAR |
| 2021-11-18 | ALGS | Grant (A) | — | $0 | EDGAR |
| 2021-03-17 | ACHV | Grant (A) | — | $0 | EDGAR |
| 2020-02-12 | KURA | Grant (A) | — | $0 | EDGAR |
| 2017-03-07 | JUNIPER PHARMACEUTICALS INC (JNP) Delisted | Grant (A) | +15,500 | $0 | EDGAR |
| 2016-07-06 | JUNIPER PHARMACEUTICALS INC (JNP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-01-09 | JUNIPER PHARMACEUTICALS INC (CBRX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–20 of 20
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.